
Acquisition - February 18, 2014
Actavis to Buy Forest Labs
Actavis PLC plans to buy Forest Laboratories Inc. for about $25 billion. “With this strategic combination, we create an innovative new model in specialty pharmaceuticals leadership, with size and scale, a balanced offering of strong brands and generics, a focus on strategic, lower-risk drug development, and – most important – the ability to drive sustainable […]